Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.
- DOI
- 10.1016/s1470-2045(26)00296-2
- Published
- 2026 Sep
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-26-00296-2,
title = {Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.},
author = {Macchia G and Morganti AG and Taylor A and Concin N and Oaknin A and Lorusso D and Vizzielli G and Nout R and González-Martín A and Pezzulla D and Deodato F and Herrera FG and Jereczek-Fossa BA and Guckenberger M},
year = {2026},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(26)00296-2},
url = {https://doi.org/10.1016/s1470-2045(26)00296-2}
}RIS
TY - JOUR TI - Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer. AU - Macchia G AU - Morganti AG AU - Taylor A AU - Concin N AU - Oaknin A AU - Lorusso D AU - Vizzielli G AU - Nout R AU - González-Martín A AU - Pezzulla D AU - Deodato F AU - Herrera FG AU - Jereczek-Fossa BA AU - Guckenberger M PY - 2026 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(26)00296-2 UR - https://doi.org/10.1016/s1470-2045(26)00296-2 ER -
APA
G, M., AG, M., A, T., N, C., A, O., D, L., G, V., R, N., A, G., D, P., F, D., FG, H., BA, J., & M, G. (2026). Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(26)00296-2
Source records
- pubmed · retrieved 2026-09-26T01:23:54.333Z